Search results for "Relationship"

showing 10 items of 3616 documents

Effects of Emotional Context on Memory for Details: The Role of Attention

2013

It was repeatedly demonstrated that a negative emotional context enhances memory for central details while impairing memory for peripheral information. This trade-off effect is assumed to result from attentional processes: a negative context seems to narrow attention to central information at the expense of more peripheral details, thus causing the differential effects in memory. However, this explanation has rarely been tested and previous findings were partly inconclusive. For the present experiment 13 negative and 13 neutral naturalistic, thematically driven picture stories were constructed to test the trade-off effect in an ecologically more valid setting as compared to previous studies…

AdultMaleVisual perceptionEye MovementsEmotionslcsh:MedicineContext (language use)BiologyYoung AdultMemoryEncoding (memory)Explicit memoryHumansAttentionChemistry (relationship)lcsh:ScienceRecognition memoryMultidisciplinaryMemory errorslcsh:REye movementRecognition PsychologyVisual Perceptionlcsh:QResearch ArticleCognitive psychologyPLoS ONE
researchProduct

The Role of Work Group in Individual Sickness Absence Behavior

2008

The purpose of our two-year follow-up study was to examine the effect of the social components of the work group, such as group absence norms and cohesion, on sickness absence behavior among individuals with varying attitudes toward work attendance. The social components were measured using a questionnaire survey, and data on sickness absence behavior were collected from the employers' records. The study population consisted of 19,306 Finnish municipal employees working in 1,847 groups (78% women). Multilevel Poisson regression modeling was applied. The direct effects of work group characteristics on sickness absence were mostly insignificant. In contrast, both of the social components of …

AdultMaleWorkPsychometricsSocial PsychologyPsychometricsHealth StatusHealth BehaviorInterpersonal relationshipsymbols.namesakeGroup cohesivenessSurveys and QuestionnairesAbsenteeismHumansInterpersonal RelationsPoisson DistributionProspective StudiesPoisson regressionWorkplaceFinlandPublic Health Environmental and Occupational HealthAttendanceQuestionnaireMental healthMental HealthAbsenteeismsymbolsFemalePsychologySocial psychologyJournal of Health and Social Behavior
researchProduct

Relationship Status as an Influence on Cybersex Activity: Cybersex, Youth, and Steady Partner

2013

The authors focus on the influence of participants' having or not having a steady partner when reference to cybersex use. Participants were 1,239 young, Spanish individuals who completed the Internet Sex Screening Test. Results showed the influence of being in a relationship on certain consumption dimensions of cybersex; the influence was found to be greater in men than in women. In general, cybersex activity was higher for single participants, although it was also significant for participants with a steady partner. The authors' findings facilitate the comprehension of the effect of new technologies in intimate human relationships.

AdultMaleYouthAdolescentFamily ConflictScreening testHuman relationshipsPersonal SatisfactionInterpersonal relationshipSex FactorsSurveys and QuestionnairesEroticaHumansMass ScreeningConsumption (economics)MotivationInternetbusiness.industryAge FactorsCybersexObject AttachmentExtramarital RelationsSelf ConceptComprehensionClinical PsychologySexual PartnersSpainCompulsive BehaviorFemaleThe InternetSexbusinessPsychologySocial psychologyNew technologies
researchProduct

Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life

2019

The treatment of patients with recurrent and/or metastatic (R/M) salivary gland adenoid cystic carcinoma (ACC) remains an unmet need.Patients with R/M disease with a history of clinical or symptomatic disease progression within 6 months and a maximum of 1 previous line of chemotherapy or a multiple kinase inhibitor received oral lenvatinib at a dose of 24 mg/day. The primary endpoint was the objective response rate; secondary endpoints included quality of life (QOL) (according to the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 Items [EORTC QLQ-C30] and the European Organization for Research and Treatment of Cancer Quality of Life Question…

AdultMaleadenoid cystic carcinoma; lenvatinib; quality of life; toxicityCancer Researchmedicine.medical_specialtyAdenoid cystic carcinomaAntineoplastic Agentslenvatinib03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSwallowingQuality of lifeInternal medicinemedicineClinical endpointHumansadenoid cystic carcinomaProspective Studies030212 general & internal medicineNeoplasm MetastasisProtein Kinase InhibitorsDose-Response Relationship Drugbusiness.industryPhenylurea CompoundstoxicityCancerCommon Terminology Criteria for Adverse EventsMiddle AgedSalivary Gland Neoplasmsmedicine.diseaseCarcinoma Adenoid CysticSurvival AnalysisSalivary Gland Adenoid Cystic Carcinomaquality of lifeOncologychemistry030220 oncology & carcinogenesisQuinolinesFemaleNeoplasm Recurrence LocalbusinessLenvatinibCancer
researchProduct

Addition of a second opioid may improve opioid response in cancer pain: preliminary data

2004

Recent experimental data suggest a possible use of an opioid combination to improve analgesia. In cancer patients, a rapid opioid escalation due to either worsening of the pain condition or the development of tolerance is a critical phase, as this condition is associated with a negative prognosis. The aim of this study was to assess the effects of adding a second opioid at low doses in patients with a poor analgesic benefit after dose escalation. Fourteen patients receiving strong opioids who had increased their dosage more than 100% in the last week unsuccessfully were randomly chosen to add a second opioid to the first using an initial equivalent dosage of 20% of the previous therapy. The…

AdultMalecancer painMaximum Tolerated DosePain medicineAnalgesicPainRisk AssessmentSeverity of Illness IndexDrug Administration ScheduleStatistics Nonparametriclaw.inventionPharmacotherapyRandomized controlled triallawNeoplasmsMedicineHumansTerminally IllProspective StudiesKarnofsky Performance StatusAdverse effectAgedPain MeasurementProbabilityTerminal CareDose-Response Relationship DrugMorphinebusiness.industryMiddle AgedClinical trialAnalgesics OpioidFentanylTreatment OutcomeOncologyOpioidopioid responseAnesthesiaopioid treatmentDrug Therapy CombinationFemaleCancer painbusinessmedicine.drug
researchProduct

Parent contributions to friendship stability during the primary school years.

2018

The present study examines whether characteristics of parents predict the stability of a child’s best friendships across the primary school years. Participants included 1,523 Finnish children (766 boys) who reported involvement in a total of 1,326 reciprocated friendship dyads in the 1st grade (M = 7.16 years old). At the onset of the study, mothers and fathers completed questionnaires describing their own parenting (i.e., behavioral control, psychological control, and affection toward the child) and depressive symptoms. Child scores for peer status (i.e., acceptance and rejection) were derived from 1st grade peer nomination data. Discrete-time survival analyses predicted the occurrence and…

AdultMalechildren (age groups)media_common.quotation_subjecteducationlapset (ikäryhmät)PsycINFOArticlePeer Group050105 experimental psychologyDevelopmental psychologyvanhempi-lapsisuhdeInterpersonal relationshipSurveys and QuestionnairesAffectionHumansInterpersonal Relationsparent-child relationship0501 psychology and cognitive sciencesParent-Child RelationsChildFinlandta515General PsychologyDepressive symptomsDepression (differential diagnoses)media_commonDepressive DisorderfriendsSchoolsParenting4. Education05 social sciencesparentsPeer grouphumanitiesFriendshipystävyysvanhemmatfriendshipFemaleNominationPsychologyystävät050104 developmental & child psychologyJournal of Family Psychology
researchProduct

Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

2018

The quantification of enzyme activity in the patient treated with enzyme replacement therapy (ERT) has been suggested as a tool for dosage individualization, so we conducted a study to evaluate the relationship between glucocerebrosidase activity and clinical response in patients with Gaucher disease type I (GD1) to ERT. The study included patients diagnosed with GD1, who were being treated with ERT, and healthy individuals. Markers based on glucocerebrosidase activity measurement in patients' leucocytes were studied: enzyme activity at 15 min. post-infusion (Act75 ) reflects the amount of enzyme that is distributed in the body post-ERT infusion, and accumulated glucocerebrosidase activity …

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyDiseaseToxicologySeverity of Illness IndexGastroenterology03 medical and health sciencesGlucocerebrosidase activity0302 clinical medicineStatistical significanceInternal medicineLeukocytesHumansMedicineEnzyme Replacement TherapyIn patientProspective Studies030212 general & internal medicineInverse correlationAgedEnzyme AssaysPharmacologyGaucher DiseaseDose-Response Relationship Drugbiologybusiness.industryArea under the curvenutritional and metabolic diseasesGeneral MedicineEnzyme replacement therapyMiddle AgedEnzyme assayTreatment Outcome030220 oncology & carcinogenesisbiology.proteinGlucosylceramidaseFemalebusinessBiomarkersFollow-Up StudiesBasic & Clinical Pharmacology & Toxicology
researchProduct

A Prospective Randomized Study of Corticosteroids as Adjuvant Drugs to Opioids in Advanced Cancer Patients

2007

This randomized controlled study evaluated the role of corticosteroids as adjuvants to opioid therapy in 76 advanced cancer patients with pain who requiring strong opioids. Patients were divided in 2 groups. Group O received conventional opioid treatment. Group OS received dexamethasone (8 mg orally) along with conventional treatment. Pain and symptom intensity, sense of well-being, and opioid escalation index and distress score were recorded at weekly intervals until death. No differences in pain intensity, opioid consumption, and opioid escalation index were found in 66 patients who survived 33 to 37 days. Corticosteroids did not provide significant additional analgesia to opioids, but p…

AdultMalecorticosteroidmedicine.medical_treatmentAnti-Inflammatory Agentslaw.invention03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled trial030502 gerontologylawNeoplasmsmedicineHumansProspective Studiesopioids in advanced cancer patientsprospective randomized studyProspective cohort studyDexamethasoneAgedPain MeasurementAged 80 and overAnalysis of VarianceChemotherapyadjuvant drugDose-Response Relationship Drugbusiness.industryPalliative CareGeneral MedicineMiddle AgedPain IntractableAnalgesics OpioidTreatment OutcomeOpioidChemotherapy Adjuvant030220 oncology & carcinogenesisAnesthesiaDrug Therapy CombinationFemale0305 other medical scienceCancer painbusinessAdjuvantFollow-Up Studiesmedicine.drugAmerican Journal of Hospice and Palliative Medicine®
researchProduct

Effect of the GLP-1 analog liraglutide on satiation and gastric sensorimotor function during nutrient-drink ingestion

2012

Background/Aim:Liraglutide, a glucagon-like peptide-1 analog, induces weight loss. We investigated whether liraglutide affects gastric accommodation and satiation by measuring the intragastric pressure (IGP) during nutrient-drink consumption and using the barostat technique.Methods:Ten healthy volunteers (HVs) were tested after placebo, 0.3, 0.6 or 1.2 mg liraglutide administration. IGP was studied during intragastric nutrient-drink (1.5 kcal ml(-1)) infusion (60 ml min(-1)), while the HVs scored their satiation on a graded scale until maximal satiation. In a separate session, isobaric distentions were performed using the barostat with stepwise increments of 2 mm Hg starting from minimal di…

AdultMaleendocrine systemmedicine.medical_specialtyManometryEndocrinology Diabetes and MetabolismTreatment outcomeMedicine (miscellaneous)SatiationSettore BIO/09 - FisiologiaBody Mass IndexBeveragesEatingDouble-Blind MethodGlucagon-Like Peptide 1Internal medicinegastric accomodation GLP-1 satiationPressuremedicineHumansIngestionNutrition and DieteticsDose-Response Relationship DrugLiraglutidebusiness.industryStomachdigestive oral and skin physiologyNauseaLiraglutidePostprandial PeriodTreatment OutcomeEndocrinologyGastric EmptyingFemaleGastrointestinal Motilitybusinessmedicine.drugInternational Journal of Obesity
researchProduct

Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins.

2013

Abstract The analytical performance and the clinical utility of a thyrotropin receptor (TSHR)–stimulating immunoglobulin (TSI) bioassay were compared with those of a TSHR-binding inhibitory immunoglobulin (TBII) assay. Limits of detection (LoD) and quantitation (LoQ), assay cutoff, and the half-maximal effective concentration (EC50) were measured. Dilution analysis was performed in sera of hyperthyroid patients with Graves disease (GD) during antithyroid treatment (ATD). Titer was defined as the first dilution step at which measurement of TSI or TBII fell below the assay cutoff. The LoD, LoQ, cutoff, and EC50 of the bioassay were 251-, 298-, 814-, and 827-fold lower than for the TBII assay.…

AdultMaleendocrine systemmedicine.medical_specialtyendocrine system diseasesSerial dilutionGraves' diseaseCHO CellsThyrotropin receptorYoung AdultCricetulusAntithyroid AgentsLimit of DetectionInternal medicineCricetinaemedicineBioassayAnimalsHumansProspective StudiesAgedDetection limitbiologyDose-Response Relationship DrugChemistryReproducibility of ResultsGeneral MedicineMiddle Agedmedicine.diseaseeye diseasesGraves DiseaseTiterEndocrinologybiology.proteinThyroid Stimulating ImmunoglobulinBiological AssayFemaleAntibodyBiomarkersImmunoglobulins Thyroid-StimulatingAmerican journal of clinical pathology
researchProduct